Commentary: Europe needs a central, transparent, and evidence based regulation process for devices
2013; Volume: 346; Issue: may07 3 Linguagem: Inglês
10.1136/bmj.f2771
ISSN1756-1833
AutoresMichaela Eikermann, Christian Gluud, Matthias Perleth, Claudia Wild, Stefan Sauerland, Iñaki Gutiérrez‐Ibarluzea, Sunya‐Lee Antoine, Jacques Demotes‐Mainard, Edmund Neugebauer,
Tópico(s)Healthcare cost, quality, practices
ResumoLast September, the European Commission published proposals to update regulations for medical devices in order to improve patient safety.1 The proposals are being discussed by the European parliament where critical debate is being led by the Committee on Environment, Public Health and Food Safety. Medical devices range from bandages to life support machines, and manufacturers classify them into four risk categories from low (such as urine drainage bags) to high risk (such as drug eluting cardiac stents) according to EU rules.2 The risk associated with the device depends on the duration of contact with the body, invasiveness, and whether it has a local or a systemic effect. Medium and high risk devices must be certified by one of the notified bodies, organisations that are accredited to assess a product’s compliance with EU legislation (CE mark). At a …
Referência(s)